Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nima Kokabi

Vascular & Interventional Radiology Atlanta, GA Medical Doctor

NPI 1932495298 CMS profile 504048

1364 Clifton Rd Ne Dept Of, Atlanta, GA 30322

Open in the dashboard

General payments

$1,048,528

635 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$151,624 paid to institutions, not to them · program years 2024–2025

Through program year 2025, Nima Kokabi of Atlanta, GA is reported in the CMS Open Payments database as having received $1,048,528 across 635 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $151,624 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $464,063 217
2024 General $362,293 219
2023 General $145,336 114
2022 General $56,569 59
2021 General $10,175 6
2020 General $9,460 13
2019 General $632 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nima Kokabi
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Nima Kokabi were reported at $464,063. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Nima Kokabi Vascular & Interventional Radiology median Middle half National median
2019 $632 $422 $125–$1,555 $163
2020 $9,460 $200 $68–$652 $114
2021 $10,175 $280 $99–$866 $132
2022 $56,569 $433 $137–$1,497 $149
2023 $145,336 $506 $152–$2,019 $160
2024 $362,293 $556 $175–$1,930 $164
2025 $464,063 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sirtex Medical Inc $676,262 440 payments
  2. Okami Medical, Inc. $206,709 80 payments
  3. Surefire Medical, Inc. $73,600 6 payments
  4. Boston Scientific Corporation $56,228 48 payments
  5. Siemens Medical Solutions USA, Inc. $9,008 7 payments
  6. Balt USA, LLC $8,507 12 payments
  7. Terumo Medical Corporation $7,378 23 payments
  8. Galvanize Therapeutics, Inc $7,200 2 payments
  9. Becton, Dickinson and Company $1,785 1 payment
  10. AstraZeneca Pharmaceuticals LP $1,278 3 payments
  11. Other $571 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $614,010 162 payments
  2. Consulting Fee $331,439 61 payments
  3. Travel and Lodging $81,984 218 payments
  4. Food and Beverage $18,095 192 payments
  5. Honoraria $3,000 2 payments
Products named General payments · program years 2019–2025
  1. SIR-Spheres Microspheres $676,103 438 payments
  2. LOBO $206,659 79 payments
  3. TRINAV INFUSION SYSTEM $73,600 6 payments
  4. TheraSphere Y90 Glass Microspheres 10 GBq $19,401 7 payments
  5. Prestige Coil System $8,507 12 payments
  6. ALIYA SYSTEM $7,200 2 payments
  7. Azur CX Detachable $5,912 12 payments
  8. TheraSphere Administration Set $5,157 5 payments
  9. EMBOLD Fibered $1,837 4 payments
  10. HYBRID Guidewire $1,353 4 payments
  11. Other $8,332 36 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Interventional Radiology: 38

Drug cost

$14

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Levofloxacin Generic 11 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 85 billing codes

Paid by Medicare

$55,622

Medicare's payments for the services billed

Medicare patients

155

Average age 72

Services billed

662

70 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 46%
Chronic kidney disease 45%
Diabetes 44%
Ischemic heart disease 43%
Cancer 34%
Depression 33%
Heart failure 28%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

635 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record